Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Jennifer D Peterson & Lawrence S Chan. (2009) Effectiveness and side effects of anti-CD20 therapy for autoantibody-mediated blistering skin diseases: A comprehensive survey of 71 consecutive patients from the Initial use to 2007. Therapeutics and Clinical Risk Management 5, pages 1-7.
Read now
Read now
Pamela Vezzoli, Emilio Berti & Angelo V Marzano. (2008) Rationale and efficacy for the use of rituximab in paraneoplastic pemphigus. Expert Review of Clinical Immunology 4:3, pages 351-363.
Read now
Read now
Fabrice Jardin. (2008) Development of autoimmunity in lymphoma. Expert Review of Clinical Immunology 4:2, pages 247-266.
Read now
Read now
Angela Antonucci, Massimino Negosanti, Michela Tabanelli & Claudio Varotti. (2007) Treatment of refractory pemphigus vulgaris with anti‐CD20 monoclonal antibody (rituximab): Five cases. Journal of Dermatological Treatment 18:3, pages 178-183.
Read now
Read now
Sara E. Billet, Sergei A. Grando & Mark R. Pittelkow. (2006) Paraneoplastic autoimmune multiorgan syndrome: Review of the literature and support for a cytotoxic role in pathogenesis. Autoimmunity 39:7, pages 617-630.
Read now
Read now
Articles from other publishers (30)
Farhat Zaheri, Hendri H. Pas, Jeroen Bremer, Joost M. Meijer, Marieke C. Bolling, Barbara Horvath & Gilles F. H. Diercks. (2022) Paraneoplastic pemphigus: A detailed case series from the Netherlands revealing atypical cases. Journal of the European Academy of Dermatology and Venereology 37:1, pages 147-153.
Crossref
Crossref
Jeffrey R. Gehlhausen, Michael P. Heffernan & Mary M. Tomayko. 2021. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
330
338.e3
.
Andrea D. Maderal, Paul Lee SalisburyIIIIII & Joseph L. Jorizzo. (2018) Desquamative gingivitis. Journal of the American Academy of Dermatology 78:5, pages 851-861.
Crossref
Crossref
Vance T. Lehman, Benjamin J. Barrick, Mark R. Pittelkow, Patrick J. Peller, Michael J. Camilleri & Julia S. Lehman. (2015) Diagnostic imaging in paraneoplastic autoimmune multiorgan syndrome: retrospective single site study and literature review of 225 patients. International Journal of Dermatology 54:4, pages 424-437.
Crossref
Crossref
Craig L. Leonardi, Michael P. Heffernan & Jennifer G. Gill. 2013. Comprehensive Dermatologic Drug Therapy. Comprehensive Dermatologic Drug Therapy
333
341.e3
.
Eduardo Calonje, Thomas Brenn & Alexander Lazar. 2012. McKee's Pathology of the Skin. McKee's Pathology of the Skin
151
179
.
Takashi ANAN, Fumiaki SHIMIZU, Yutaka HATANO, Osamu OKAMOTO, Kazumoto KATAGIRI & Sakuhei FUJIWARA. (2011) Paraneoplastic pemphigus associated with corneal perforation and cutaneous alternariosis: A case report and review of cases treated with rituximab. The Journal of Dermatology 38:11, pages 1084-1089.
Crossref
Crossref
John W. Frew & Dédée F. Murrell. (2011) Current Management Strategies in Paraneoplastic Pemphigus (Paraneoplastic Autoimmune Multiorgan Syndrome). Dermatologic Clinics 29:4, pages 607-612.
Crossref
Crossref
Batya B. Davidovici & Ronni Wolf. 2011. Emergency Dermatology. Emergency Dermatology
34
49
.
David R. Carr & Michael P. Heffernan. (2010) Innovative Uses of Rituximab in Dermatology. Dermatologic Clinics 28:3, pages 547-557.
Crossref
Crossref
Sang Eun Lee & Soo-Chan Kim. (2010) Paraneoplastic pemphigus. Dermatologica Sinica 28:1, pages 1-14.
Crossref
Crossref
Thomas Dörner, David Isenberg, David Jayne, Heinz Wiendl, Detlef Zillikens & Gerd Burmester. (2009) Current status on B-cell depletion therapy in autoimmune diseases other than rheumatoid arthritis. Autoimmunity Reviews 9:2, pages 82-89.
Crossref
Crossref
Si-Xuan Qian, Jian-Yong Li, Ming Hong, Wei Xu & Hong-xia Qiu. (2009) Nonhematological autoimmunity (glomerulosclerosis, paraneoplastic pemphigus and paraneoplastic neurological syndrome) in a patient with chronic lymphocytic leukemia: Diagnosis, prognosis and management. Leukemia Research 33:3, pages 500-505.
Crossref
Crossref
. 2009. Oral and Maxillofacial Pathology. Oral and Maxillofacial Pathology
741
815
.
Mohammad Diab, Mark Bechtel, Jacquelyn Coloe, Eleanor Kurtz & Mark Ranalli. (2008) Treatment of refractory pemphigus erythematosus with rituximab. International Journal of Dermatology 47:12, pages 1317-1318.
Crossref
Crossref
Martijn Meijs, Jan Mekkes, Carel van Noesel, Erik Nijhuis, Onno Leeksma, Marcel Jonkman & Rick Hoekzema. (2008) Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma without Castleman's disease; treatment with rituximab. International Journal of Dermatology 47:6, pages 632-634.
Crossref
Crossref
G. Guhl, B. Díaz-Ley & J. Fernández-Herrera. (2008) Uso de fármacos biológicos en dermatosis fuera de la indicación aprobada. Segunda parte: etanercept, efalizumab, alefacept, rituximab, daclizumab, basiliximab, omalizumab y cetuximab. Actas Dermo-Sifiliográficas 99:1, pages 5-33.
Crossref
Crossref
G. Guhl, B. Díaz-Ley & J. Fernández-Herrera. (2008) Off-Label Use of Biologic Agents in the Treatment of Dermatosis, Part 2: Etanercept, Efalizumab, Alefacept, Rituximab, Daclizumab, Basiliximab, Omalizumab, and Cetuximab. Actas Dermo-Sifiliográficas (English Edition) 99:1, pages 5-33.
Crossref
Crossref
Xuejun ZHU & Bingxin ZHANG. (2007) Paraneoplastic pemphigus. The Journal of Dermatology 34:8, pages 503-511.
Crossref
Crossref
David R Carr & Michael P Heffernan. (2007) Off-label uses of rituximab in dermatology. Dermatologic Therapy 20:4, pages 277-287.
Crossref
Crossref
Mousumee Nanda, Arti Nanda, Humoud Al-Sabah, Richard Dvorak & Qasem A. Alsaleh. (2007) Paraneoplastic pemphigus in association with B-cell lymphocytic leukemia and hepatitis C: favorable response to intravenous immunoglobulins and prednisolone. International Journal of Dermatology 46:7, pages 767-769.
Crossref
Crossref
Klaudia Preisz & Sarolta Kárpáti. (2007) Paraneoplastic pemphigus. Orvosi Hetilap 148:21, pages 979-983.
Crossref
Crossref
Adam R. Taintor, Kristin M. Leiferman, Takashi Hashimoto, Norito Ishii, John J. Zone & Christopher M. Hull. (2007) A novel case of IgA paraneoplastic pemphigus associated with chronic lymphocytic leukemia. Journal of the American Academy of Dermatology 56:5, pages S73-S76.
Crossref
Crossref
S. R. Hoque, M. M. Black & S. Cliff. (2007) Paraneoplastic pemphigus associated with CD20-positive follicular non-Hodgkin's lymphoma treated with rituximab: a third case resistant to rituximab therapy. Clinical and Experimental Dermatology 32:2, pages 172-175.
Crossref
Crossref
Julia E. Graves, Kara Nunley & Michael P. Heffernan. (2007) Off-label uses of biologics in dermatology: Rituximab, omalizumab, infliximab, etanercept, adalimumab, efalizumab, and alefacept (Part 2 of 2). Journal of the American Academy of Dermatology 56:1, pages e55-e79.
Crossref
Crossref
Mary Jo. J. Kerns, Julia E. Graves, David I. Smith & Michael P. Heffernan. (2006) Off-Label Uses of Biologic Agents in Dermatology: A 2006 Update. Seminars in Cutaneous Medicine and Surgery 25:4, pages 226-240.
Crossref
Crossref
Mitra M. Fatourechi, Rokea A. el-Azhary & Lawrence E. Gibson. (2006) Rituximab: Applications in dermatology. International Journal of Dermatology 45:10, pages 1143-1155.
Crossref
Crossref
E. Schmidt, N. Hunzelmann, D. Zillikens, E.-B. Brocker & M. Goebeler. (2006) Rituximab in refractory autoimmune bullous diseases. Clinical and Experimental Dermatology 31:4, pages 503-508.
Crossref
Crossref
MA Barnadas, E Roe, S Brunet, P Garcia, P Bergua, L Pimentel, L Puig, A Francia, R Garcia, C Gelpi, J Sierra, P Coll & A Alomar. (2006) Therapy of paraneoplastic pemphigus with Rituximab: a case report and review of literature. Journal of the European Academy of Dermatology and Venereology 20:1, pages 69-74.
Crossref
Crossref
Gerard Pitarch, José L. Sánchez-Carazo, José Pardo, Arantxa Torrijos, Elena Roche & José M. Fortea. (2006) Tratamiento de pénfigo vulgar grave resistente con rituximab. Actas Dermo-Sifiliográficas 97:1, pages 48-51.
Crossref
Crossref